Production of Secretory Diarrhea by Intravenous Infusion of Vasoactive Intestinal Polypeptide
- 15 December 1983
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 309 (24) , 1482-1485
- https://doi.org/10.1056/nejm198312153092403
Abstract
We attempted to reproduce the diarrhea of pancreatic cholera syndrome with prolonged (10-hour) administration of vasoactive intestinal polypeptide (VIP) in five healthy nonfasting subjects. The polypeptide was given as a continuous intravenous infusion at a rate of 400 pmol per kilogram of body weight per hour. By two hours the plasma VIP concentration had risen from a normal basal value of 15.3±0.2 (mean ±S.E.M.) to 129±40 pmol per liter — within the range found in patients with pancreatic cholera syndrome. In each subject profuse watery diarrhea developed within 4.3±0.8 hours (range, 2.0 to 6.3), and the mean stool weight at 10 hours was 2441±600 g (normal 24-hour stool weight, <200 to 250 g). The results of stool analysis were consistent with secretory diarrhea. Between the first and last stool, there were significant increases in fecal sodium and bicarbonate concentrations and in pH. The large fecal bicarbonate loss induced hyperchloremic metabolic acidosis, which is characteristic in patients with pancreatic cholera syndrome.Keywords
This publication has 19 references indexed in Scilit:
- Starch Blockers — Their Effect on Calorie Absorption from a High-Starch MealNew England Journal of Medicine, 1982
- Effect of vasoactive intestinal polypeptide on active and passive transport in the human jejunum.Journal of Clinical Investigation, 1981
- Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).BMJ, 1981
- Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndromeWorld Journal of Surgery, 1979
- Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transportin vivoDigestive Diseases and Sciences, 1979
- Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.Gut, 1978
- Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatmentDigestive Diseases and Sciences, 1978
- Cure of intractable watery diarrhoea by excision of a vipomaBritish Journal of Surgery, 1978
- Elevated Plasma and Tissue Levels of Vasoactive Intestinal Polypeptide in the Watery-Diarrhea Syndrome Due to Pancreatic, Bronchogenic and Other TumorsNew England Journal of Medicine, 1975
- Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemiaThe American Journal of Medicine, 1958